Past exposure to vaccines and subsequent risk of Alzheimer's disease
- PMID: 11762573
- PMCID: PMC81665
Past exposure to vaccines and subsequent risk of Alzheimer's disease
Abstract
Background: It has been suggested that changes to the immune system could be a factor in age-related conditions such as Alzheimer's disease. Our objective was to examine the association between past exposure to conventional vaccines and risk of Alzheimer's disease.
Methods: We analyzed data from a representative community sample of subjects 65 years of age or older participating in the Canadian Study of Health and Aging, a prospective cohort study of dementia. Screening and clinical evaluations were done at both baseline and follow-up. Past exposure to vaccines was assessed at baseline by means of a self-administered questionnaire.
Results: Of the 4392 eligible subjects who were cognitively unimpaired and for whom vaccine information was available at baseline (in 1991-1992) and who completed follow-up 5 years later (in 1996-1997), 527 were diagnosed as having cognitive impairment or dementia other than Alzheimer's disease and were excluded from these analyses. Of the remaining subjects, 3682 were cognitively unimpaired at follow-up and 183 were newly diagnosed as having Alzheimer's disease. After adjustment for age, sex and education, past exposure to vaccines against diphtheria or tetanus, poliomyelitis and influenza was associated with lower risk for Alzheimer's disease (odds ratio [OR] 0.41, 95% confidence interval [CI] 0.27-0.62; OR 0.60, 95% CI 0.37-0.99; and OR 0.75, 95% CI 0.54-1.04 respectively) than no exposure to these vaccines.
Interpretation: Past exposure to vaccines against diphtheria or tetanus, poliomyelitis and influenza may protect against subsequent development of Alzheimer's disease.
Comment in
-
Alzheimer's disease and herpes.CMAJ. 2002 Jul 9;167(1):13. CMAJ. 2002. PMID: 12137067 Free PMC article. No abstract available.
Similar articles
-
Exercise: a potential contributing factor to the relationship between folate and dementia.J Am Geriatr Soc. 2007 Jul;55(7):1095-8. doi: 10.1111/j.1532-5415.2007.01238.x. J Am Geriatr Soc. 2007. PMID: 17608885
-
Canadian study of health and aging: study methods and prevalence of dementia.CMAJ. 1994 Mar 15;150(6):899-913. CMAJ. 1994. PMID: 8131123 Free PMC article.
-
Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease.N Engl J Med. 2001 Nov 22;345(21):1515-21. doi: 10.1056/NEJMoa010178. N Engl J Med. 2001. PMID: 11794217
-
[Review of studies on exposure to aluminum and Alzheimer's disease].Rev Esp Salud Publica. 2002 Nov-Dec;76(6):645-58. Rev Esp Salud Publica. 2002. PMID: 12602134 Review. Spanish.
-
Elements of mobility as predictors of survival in elderly patients with dementia: findings from the Canadian Study of Health and Aging.Chronic Dis Can. 2000;21(3):93-103. Chronic Dis Can. 2000. PMID: 11082345 Review.
Cited by
-
Gram-negative bacterial molecules associate with Alzheimer disease pathology.Neurology. 2016 Nov 29;87(22):2324-2332. doi: 10.1212/WNL.0000000000003391. Epub 2016 Oct 26. Neurology. 2016. PMID: 27784770 Free PMC article.
-
Peripheral Pathways to Neurovascular Unit Dysfunction, Cognitive Impairment, and Alzheimer's Disease.Front Aging Neurosci. 2022 Apr 18;14:858429. doi: 10.3389/fnagi.2022.858429. eCollection 2022. Front Aging Neurosci. 2022. PMID: 35517047 Free PMC article. Review.
-
Role of infection in the pathogenesis of Alzheimer's disease: implications for treatment.CNS Drugs. 2009 Dec;23(12):993-1002. doi: 10.2165/11310910-000000000-00000. CNS Drugs. 2009. PMID: 19958038 Review.
-
Viral Induced Oxidative and Inflammatory Response in Alzheimer's Disease Pathogenesis with Identification of Potential Drug Candidates: A Systematic Review using Systems Biology Approach.Curr Neuropharmacol. 2019;17(4):352-365. doi: 10.2174/1570159X16666180419124508. Curr Neuropharmacol. 2019. PMID: 29676229 Free PMC article.
-
Drug prescriptions and dementia incidence: a medication-wide association study of 17000 dementia cases among half a million participants.J Epidemiol Community Health. 2022 Mar;76(3):223-229. doi: 10.1136/jech-2021-217090. Epub 2021 Oct 27. J Epidemiol Community Health. 2022. PMID: 34706926 Free PMC article.
References
-
- Chorsky RL, Yaghmai F, Hill WD, Stopa EG. Alzheimer's disease: a review concerning immune response and microischemia. Med Hypotheses 2001; 56: 124-7. - PubMed
-
- Armstrong R, Winsper S, Blair J. Hypothesis: Is Alzheimer's disease a metal-induced immune disorder? Neurodegeneration 1995;4:107-11. - PubMed
-
- Renvoize EB, Awad IO, Hambling MH. A sero-epidemiological study of conventional infectious agents in Alzheimer's disease. Age Ageing 1987;16:311-4. - PubMed
-
- Cheon MS, Bajo M, Gulesserian T, Cairns N, Lubec G. Evidence for the relation of herpes simplex virus type 1 to Down syndrome and Alzheimer's disease. Electrophoresis 2001;22:445-8. - PubMed
-
- Effros RB. Ageing and the immune system. Novartis Found Symp 2001;235: 130-9. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous